{
  "1": [
    [
      ""
    ]
  ],
  "ipo_details": [
    [
      "IPO Date",
      "August 19, 2025 to August 21, 2025"
    ],
    [
      "Listing Date",
      "[.]"
    ],
    [
      "Face Value",
      "₹2per share"
    ],
    [
      "Issue Price Band",
      "₹309 to ₹325 per share"
    ],
    [
      "Lot Size",
      "46 Shares"
    ],
    [
      "Sale Type",
      "Fresh Capital-cum-Offer for Sale"
    ],
    [
      "Total Issue Size",
      "1,38,84,615shares(aggregating up to ₹451.25Cr)"
    ],
    [
      "Fresh Issue",
      "53,84,615shares(aggregating up to ₹175.00Cr)"
    ],
    [
      "Offer for Sale",
      "85,00,000shares of ₹2(aggregating up to ₹276.25Cr)"
    ],
    [
      "Issue Type",
      "BookbuildingIPO"
    ],
    [
      "Listing At",
      "BSE, NSE"
    ],
    [
      "Share Holding Pre Issue",
      "4,68,52,523shares"
    ],
    [
      "Share Holding Post Issue",
      "5,22,37,138shares"
    ]
  ],
  "reservation": [
    {
      "Investor Category": "QIB Shares Offered",
      "Shares Offered": "Not more than 50.00% of the Net Issue"
    },
    {
      "Investor Category": "Retail Shares Offered",
      "Shares Offered": "Not less than 35.00% of the Net Issue"
    },
    {
      "Investor Category": "NII Shares Offered",
      "Shares Offered": "Not less than 15.00% of the Net Issue"
    }
  ],
  "timeline": [
    [
      "IPO Open Date",
      "Tue, Aug 19, 2025"
    ],
    [
      "IPO Close Date",
      "Thu, Aug 21, 2025"
    ],
    [
      "Tentative Allotment",
      "Fri, Aug 22, 2025"
    ],
    [
      "Initiation of Refunds",
      "Mon, Aug 25, 2025"
    ],
    [
      "Credit of Shares to Demat",
      "Mon, Aug 25, 2025"
    ],
    [
      "Tentative Listing Date",
      "Tue, Aug 26, 2025"
    ],
    [
      "Cut-off time for UPI mandate confirmation",
      "5 PM onAugust 21, 2025"
    ]
  ],
  "lots": [
    {
      "Application": "Retail (Min)",
      "Lots": "1",
      "Shares": "46",
      "Amount": "₹14,950"
    },
    {
      "Application": "Retail (Max)",
      "Lots": "13",
      "Shares": "598",
      "Amount": "₹1,94,350"
    },
    {
      "Application": "S-HNI (Min)",
      "Lots": "14",
      "Shares": "644",
      "Amount": "₹2,09,300"
    },
    {
      "Application": "S-HNI (Max)",
      "Lots": "66",
      "Shares": "3,036",
      "Amount": "₹9,86,700"
    },
    {
      "Application": "B-HNI (Min)",
      "Lots": "67",
      "Shares": "3,082",
      "Amount": "₹10,01,650"
    }
  ],
  "promoters_holdings": [
    [
      "Share Holding Pre Issue",
      "75%"
    ],
    [
      "Share Holding Post Issue",
      "55.06%"
    ]
  ],
  "company_financials": [
    [
      "Period Ended",
      "31 Mar 2025",
      "31 Mar 2024",
      "31 Mar 2023"
    ],
    [
      "Assets",
      "534.52",
      "368.57",
      "295.76"
    ],
    [
      "Total Income",
      "505.64",
      "454.23",
      "425.09"
    ],
    [
      "Profit After Tax",
      "53.38",
      "50.10",
      "44.67"
    ],
    [
      "EBITDA",
      "88.45",
      "78.35",
      "66.19"
    ],
    [
      "Net Worth",
      "283.98",
      "230.55",
      "179.53"
    ],
    [
      "Reserves and Surplus",
      "278.26",
      "224.88",
      "182.36"
    ],
    [
      "Total Borrowing",
      "222.37",
      "111.13",
      "89.36"
    ],
    [
      "Amount in ₹ Crore"
    ]
  ],
  "KPI": [
    {
      "KPI": "ROE",
      "Values": "18.80%"
    },
    {
      "KPI": "ROCE",
      "Values": "16.02%"
    },
    {
      "KPI": "Debt/Equity",
      "Values": "0.78"
    },
    {
      "KPI": "RoNW",
      "Values": "18.80%"
    },
    {
      "KPI": "PAT Margin",
      "Values": "10.56%"
    },
    {
      "KPI": "EBITDA Margin",
      "Values": "17.55%"
    },
    {
      "KPI": "Price to Book Value",
      "Values": "5.36"
    }
  ],
  "EPS": [
    {
      "": "EPS (Rs)",
      "Pre IPO": "11.39",
      "Post IPO": "10.22"
    },
    {
      "": "P/E (x)",
      "Pre IPO": "28.52",
      "Post IPO": "31.8"
    }
  ],
  "objectives": [
    {
      "S.No.": "1",
      "Objects of the Issue": "Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by our Company and our Subsidiary, Krystal Ingredients Private Limited; and",
      "Expected Amount(₹ in crores)": "140.00"
    },
    {
      "S.No.": "2",
      "Objects of the Issue": "General Corporate Purposes",
      "Expected Amount(₹ in crores)": ""
    }
  ],
  "review": [
    {
      "Review By": "Brokers",
      "Subscribe": "0",
      "Neutral": "0",
      "Avoid": "0"
    },
    {
      "Review By": "Members",
      "Subscribe": "0",
      "Neutral": "0",
      "Avoid": "0"
    }
  ],
  "12": [
    [
      ""
    ]
  ],
  "prospectus_links": [
    {
      "title": "Gem Aromatics IPO DRHP",
      "href": "https://www.sebi.gov.in/filings/public-issues/jan-2025/gem-aromatics-limited_90548.html",
      "text": "Gem Aromatics IPODRHP"
    }
  ],
  "promoters": "The promoters of the company are Vipul Parekh, Kaksha Vipul Parekh, Yash Vipul Parekh, and Parekh Family Trust.",
  "company_contact_details": {
    "company_name": "Gem Aromatics Ltd.",
    "address": "A/410, Kailas Complex, Vikhroli Powai Link, Road, Park Site,, Vikhroli (W), Mumbai, ,, Maharashtra, , 400079, Phone, :, Email, :, Website, :",
    "phone": "+91 22 25185231",
    "email": "secretarial@gemaromatics.in",
    "website": "http://www.gemaromatics.com/"
  },
  "ipo_registrar_details": {
    "name": "Kfin Technologies Ltd.",
    "phone": "04067162222",
    "email": "gem.ipo@motilaloswal.com",
    "website": "https://ipostatus.kfintech.com/"
  },
  "about_company": {
    "description": "Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India, with over two decades of experience. The company offers various products, from Mother Ingredients to Value-Added Derivatives. The company's products are used in oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness, pain management, and personal care. The company provides a total of seventy products, categorized into four distinct groups, which include: In Fiscal 2025, the company serves 225 customers and 44  international customers across 18 countries, including the Americas, Asia, Africa, and Australia. The company sells products directly to customers on a business-to-business basis, with export sales through methods including (i) direct sales, (ii) sales via its subsidiary, Gem Aromatics LLC, in the USA, and (iii) sales through third-party agencies. As of Mar 31, 2025, the company had an in-house R&D team of 13 scientists who pivotally implemented state-of-the-art technology that advanced our formulations in Value-Added Derivatives. Competitive Strength",
    "competitive_strengths": [
      "Mint and its derivatives;;",
      "Clove and its derivatives;",
      "Phenol; and",
      "Other synthetic and natural ingredients."
    ]
  },
  "ipo_lead_managers": [
    {
      "name": "Motilal Oswal Investment Advisors Ltd.",
      "profile_link": "/report/ipo-lead-manager-review/112/28/",
      "title": "About Motilal Oswal Investment Advisors Ltd."
    }
  ],
  "listing_gain_percent": null
}